F&P Healthcare reports ‘strong result’ in first half For Homecare, company saw 10% increase in revenues
By HME News Staff
Updated 10:57 AM CST, Wed November 26, 2025
.jpg)
AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported total operating revenue of $1.09 billion for the first half of the 2026 financial year, a 14% increase year over year. Net profit after tax was $213 million, a 39% increase.
“Our people have continued to work closely with clinicians, progress work on new products and deliver a range of efficiency improvements across the business,” said Managing Director and CEO Lewis Gradon. “This is a strong result against the backdrop of robust growth in the first half of last year. We saw broad-based strength across the Hospital consumables portfolio during a period of lower seasonal respiratory hospitalizations, and in Homecare, our latest range of masks for treating obstructive sleep apnea has performed well.”
For the Homecare product group, which includes products used in the treatment of obstructive sleep apnea (OSA) and respiratory support in the home, F&P reported revenue of $395.9 million for the first half of the year, a 10% increase. The company reported a 6% increase in revenue, on a constant currency basis, for OSA masks and accessories, specifically.
F&P says it now expects full-year operating revenue in the range of about $2.17 billion to $2.27 billion, up from $2.15 billion to $2.25 billion; and full-year net profit after tax in the range of about $410 million to $460 million, up from $390 million to $440 million.
Comments